Skip to content
buyNotable cluster of 2

Vivek Garipalli bought $999k of CLOV

director, owner at CLOVER HEALTH INVESTMENTS, CORP. /DE. 446,980 shares at an average of $2.24, traded Aug 7, 2025, filed Aug 8, 2025.

Conviction score
72
Value
$999k
446,980 shares
Holdings after
1,856,247
+32% from before
From 52-week low
0%
low $2.21, close $2.21
From 52-week high
-54%
high $4.82, as of Aug 7, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $999k at market
    +25
  • Relative to holdings
    Holdings up 32%
    +6
  • Price context
    0% above the 52-week low; 54% below the 52-week high
    +18
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +26.1%, 3m +22.5%, 6m -2.3%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CLOVOct 12, 2026 · close 4.78
Since filing Aug 8, 2025: +119.3%SPY +23.8% · excess +95.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001801170-25-000207, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 7, 2025POpen-market purchase
Class A Common Stock
+415,000$2.24$930k1,824,267Aug 8, 2025
Aug 8, 2025POpen-market purchase
Class A Common Stock
+31,980$2.17$69k1,856,247Aug 8, 2025

Related signals

Other insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 14, 2026
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$9,288
2,006 shares
-0%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$39k
8,750 shares
-0%
38Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Andrew Toy
Chief Executive Officer
$1.3M
318,806 shares
-3%
20Weak
CLOVsell 510b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$8,760
1,921 shares
-0%
10Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$15k
3,170 shares
-1%
50Moderate
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Conrad Wai
CEO, Counterpart Health
$1.4M
300,000 shares
-20%
26Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jamie L. Reynoso
CEO, Medicare Advantage
$44k
9,273 shares
-0%
16Weak
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Karen Soares
Chief Legal Officer
$33k
6,846 shares
-0%
40Moderate
CLOVsell 4
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Frank Oldakowski
VP OF FINANCE AND CONTROLLER
$103k
20,000 shares
-7%
19Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
Joseph Clay Thornton
Interim CFO
$78k
17,775 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Vivek Garipalli bought $999k of CLOV | InsiderTell